CD11c+ Blood Dendritic Cells Induce Antigen-specific Cytotoxic T Lymphocytes With Similar Efficiency Compared to Monocyte-derived Dendritic Cells Despite Higher Levels of MHC Class I Expression
- 1 November 2006
- journal article
- research article
- Published by Wolters Kluwer Health in Journal of Immunotherapy
- Vol. 29 (6) , 596-605
Abstract
Dendritic cell (DC) immunotherapy for cancer has shown promising results in phase I and II clinical trials. Most studies have used monocyte-derived DCs (MoDCs) but their poor migratory capacity in vivo has emerged as a key issue. The natural circulating peripheral blood CD11c+ DC precursors (BDCs) may be an attractive alternative to MoDCs, as they can be isolated rapidly in sufficient quantities, and have superior migratory and T helper-1-inducing capacity in vitro. We performed the first comparative analysis of the ability of autologous BDCs and MoDCs in healthy donors to induce tumor-specific cytotoxic T lymphocytes (CTLs). BDCs expressed significantly higher levels of major histocompatibility complex class I and CD83 in the absence of exogenous stimuli compared with MoDCs. After activation with polyinosinic-polycytidylic acid, BDCs expressed higher levels of major histocompatibility complex class I, CD40, CD80, and CD83, and secreted higher levels of tumor necrosis factor-alpha, interleukin (IL)-1beta, IL-6, and IL-8 compared with MoDCs. Despite these differences, both preparations secreted similar levels of IL-12 in response to polyinosinic-polycytidylic acid and, importantly, induced CTL responses of similar magnitude and affinity against influenza matrix protein and MART-1. The ability of BDCs to induce efficient CTL responses, combined with their migratory capacity, makes them an appealing alternative to be investigated in clinical immunotherapy research protocols.Keywords
This publication has 56 references indexed in Scilit:
- Numerical and functional assessment of blood dendritic cells in prostate cancer patientsThe Prostate, 2005
- Serum Concentration of the Growth Medium Markedly Affects Monocyte‐Derived Dendritic Cells' Phenotype, Cytokine Production Profile and Capacities to Stimulate in MLRScandinavian Journal of Immunology, 2004
- Mechanisms and functional significance of tumour-induced dendritic-cell defectsNature Reviews Immunology, 2004
- Toll-like receptor control of the adaptive immune responsesNature Immunology, 2004
- α-Type-1 Polarized Dendritic CellsCancer Research, 2004
- Tuning the volume of the immune response: strength and persistence of stimulation determine migration and cytokine secretion of dendritic cellsBlood, 2004
- Poly(I:C) used for human dendritic cell maturation preserves their ability to secondarily secrete bioactive IL-12International Immunology, 2004
- Signal 3 Determines Tolerance versus Full Activation of Naive CD8 T CellsJournal of Experimental Medicine, 2003
- Subsets of Human Dendritic Cell Precursors Express Different Toll-like Receptors and Respond to Different Microbial AntigensJournal of Experimental Medicine, 2001
- A comparison of two types of dendritic cell as adjuvants for the induction of melanoma-specific T-cell responses in humans following intranodal injectionInternational Journal of Cancer, 2001